GenMark Diagnostics EBITDA 2010-2019 | GNMK

GenMark Diagnostics ebitda from 2010 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
GenMark Diagnostics Annual EBITDA
(Millions of US $)
2019 $-33
2018 $-40
2017 $-53
2016 $-45
2015 $-38
2014 $-36
2013 $-32
2012 $-21
2011 $-23
2010 $-19
2009 $1
GenMark Diagnostics Quarterly EBITDA
(Millions of US $)
2019-12-31 $-6
2019-09-30 $-8
2019-06-30 $-10
2019-03-31 $-9
2018-12-31 $-9
2018-09-30 $-9
2018-06-30 $-14
2018-03-31 $-9
2017-12-31 $-12
2017-09-30 $-13
2017-06-30 $-16
2017-03-31 $-12
2016-12-31 $-11
2016-09-30 $-11
2016-06-30 $-12
2016-03-31 $-12
2015-12-31 $-7
2015-09-30 $-10
2015-06-30 $-11
2015-03-31 $-9
2014-12-31 $-8
2014-09-30 $-9
2014-06-30 $-10
2014-03-31 $-8
2013-12-31 $-9
2013-09-30 $-11
2013-06-30 $-7
2013-03-31 $-4
2012-12-31 $-4
2012-09-30 $-6
2012-06-30 $-5
2012-03-31 $-5
2011-12-31 $-5
2011-09-30 $-6
2011-06-30 $-5
2011-03-31 $-6
2010-12-31 $-10
2010-09-30 $-5
2010-06-30 $-5
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.250B $0.088B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $112.928B 22.95
Intuitive Surgical (ISRG) United States $58.547B 43.42
Edwards Lifesciences (EW) United States $41.707B 35.81
ALCON INC (ALC) Switzerland $23.570B 0.00
DexCom (DXCM) United States $22.918B 136.73
IDEXX Laboratories (IDXX) United States $19.658B 47.21
Fresenius Medical Care AG KGaA (FMS) Germany $19.129B 12.67
Olympus (OCPNY) Japan $18.833B 141.44
Sysmex ADR (SSMXY) Japan $14.401B 40.59
Teleflex (TFX) United States $13.445B 26.01
SONOVA HOLDING (SONVY) Switzerland $11.508B 0.00
STERIS (STE) Ireland $10.993B 23.44
Varian Medical Systems (VAR) United States $9.812B 22.83
Masimo (MASI) United States $9.274B 54.00
Hologic (HOLX) United States $8.958B 13.77
SARTORIUS AG (SARTF) Germany $7.766B 69.00
ABIOMED (ABMD) United States $6.722B 35.43
Penumbra (PEN) United States $5.576B 164.00
Globus Medical (GMED) United States $4.303B 25.50
Tandem Diabetes Care (TNDM) United States $3.892B 0.00
Wright Medical Group (WMGI) Netherlands $3.697B 410.29
Integra LifeSciences Holdings (IART) United States $3.443B 14.88
Nevro (NVRO) United States $3.033B 0.00
Elekta AB (EKTAY) Sweden $2.995B 23.06
Nihon Kohden (NHNKY) Japan $2.830B 28.48
LivaNova (LIVN) United Kingdom $2.065B 15.06
Integer Holdings (ITGR) United States $1.985B 12.93
Glaukos (GKOS) United States $1.627B 0.00
Cantel Medical (CMD) United States $1.502B 14.45
Veracyte (VCYT) United States $1.224B 0.00
Luminex (LMNX) United States $1.223B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.222B 23.91
Inogen (INGN) United States $1.209B 51.30
ShockWave Medical (SWAV) United States $1.098B 0.00
Silk Road Medical (SILK) United States $1.044B 0.00
Mesa Laboratories (MLAB) United States $0.962B 50.38
OPKO Health (OPK) United States $0.924B 0.00
Natus Medical (NTUS) United States $0.787B 18.46
Tactile Systems Technology (TCMD) United States $0.772B 71.73
CryoLife (CRY) United States $0.635B 52.45
OrthoPediatrics (KIDS) United States $0.612B 0.00
Pacific Biosciences Of California (PACB) United States $0.547B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.530B 18.78
Accelerate Diagnostics (AXDX) United States $0.445B 0.00
Intersect ENT (XENT) United States $0.410B 0.00
AngioDynamics (ANGO) United States $0.403B 18.48
AxoGen (AXGN) United States $0.386B 0.00
ViewRay (VRAY) United States $0.372B 0.00
Si-Bone (SIBN) United States $0.312B 0.00
Quotient (QTNT) Switzerland $0.301B 0.00
TransMedics (TMDX) United States $0.273B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.259B 0.00
Alphatec Holdings (ATEC) United States $0.233B 0.00
IRadimed (IRMD) United States $0.233B 26.41
Semler Scientific (SMLR) United States $0.229B 27.42
SeaSpine Holdings (SPNE) United States $0.217B 0.00
Stereotaxis (STXS) United States $0.184B 0.00
Fluidigm (FLDM) United States $0.169B 0.00
Accuray (ARAY) United States $0.159B 0.00
RTI Surgical (RTIX) United States $0.155B 42.00
Restoration Robotics (VERO) Canada $0.117B 0.00
Sientra (SIEN) United States $0.115B 0.00
Electromed (ELMD) United States $0.103B 28.14
CRH Medical (CRHM) Canada $0.094B 26.20
Spectral Diagnostics (EDTXF) Canada $0.085B 0.00
Vermillion (VRML) United States $0.072B 0.00
Allied Healthcare Products (AHPI) United States $0.067B 0.00
EDAP TMS S.A (EDAP) France $0.066B 17.61
MRI Interventions (CLPT) United States $0.059B 0.00
ConforMIS (CFMS) United States $0.050B 0.00
Sensus Healthcare (SRTS) United States $0.046B 0.00
Apollo Endosurgery (APEN) United States $0.045B 0.00
Second Sight Medical Products (EYES) United States $0.043B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Neuronetics (STIM) United States $0.031B 0.00
Bioanalytical Systems (BASI) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
Neovasc (NVCN) Canada $0.020B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.019B 0.00
TransEnterix (TRXC) United States $0.018B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.016B 0.00
Ra Medical Systems (RMED) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
Sunshine Heart Inc (CHFS) United States $0.009B 0.00
American Shared Hospital Services (AMS) United States $0.009B 12.92
Helius Medical Technologies (HSDT) United States $0.009B 0.00
Xtant Medical Holdings (XTNT) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Lianluo Smart (LLIT) China $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
ReWalk Robotics (RWLK) Israel $0.006B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00